Alzheimer's & Dementia

Alzheimer’s disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills. Alzheimer’s is the most common cause of dementia among older adults. Dementia is the loss of cognitive functioning—thinking, remembering, and reasoning—and behavioral abilities to such an extent that it interferes with a person’s daily life and activities.

Overview

Feature Articles

Latest Alzheimer's & Dementia News and Research

New genetic risk factors for Alzheimer’s disease unique to Ashkenazi Jews identified

New genetic risk factors for Alzheimer’s disease unique to Ashkenazi Jews identified

Pilot study reveals effective approach to boost adherence to Mediterranean ketogenic diet for memory concerns in older adults

Pilot study reveals effective approach to boost adherence to Mediterranean ketogenic diet for memory concerns in older adults

Study explores the link between sleep apnea and brain volume

Study explores the link between sleep apnea and brain volume

Environmental enrichment may reduce early accumulation of amyloid plaques in Alzheimer's mouse model

Environmental enrichment may reduce early accumulation of amyloid plaques in Alzheimer's mouse model

Biomarker study reveals the effects of astrocyte reactivity in preclinical Alzheimer's disease

Biomarker study reveals the effects of astrocyte reactivity in preclinical Alzheimer's disease

Early life hardships echo into old age: Study links childhood adversity to cognitive decline in later life

Early life hardships echo into old age: Study links childhood adversity to cognitive decline in later life

Boiled coffee overload: Consuming six or more cups daily linked to higher dementia and Alzheimer's risk

Boiled coffee overload: Consuming six or more cups daily linked to higher dementia and Alzheimer's risk

Hypertension is silent culprit in 15.8% of global dementia cases

Hypertension is silent culprit in 15.8% of global dementia cases

Research finds more depressed patients with activated immune systems than previously estimated

Research finds more depressed patients with activated immune systems than previously estimated

Study finds significantly faster decline in cognition over the years after a heart attack

Study finds significantly faster decline in cognition over the years after a heart attack

Low sexual satisfaction in mid-life may signal future cognitive decline

Low sexual satisfaction in mid-life may signal future cognitive decline

New research shows astrocytes are key to swaying the pendulum in Alzheimer's disease progression

New research shows astrocytes are key to swaying the pendulum in Alzheimer's disease progression

Novel assay for identifying individuals with synucleinopathies using serum samples

Novel assay for identifying individuals with synucleinopathies using serum samples

Two key physiological systems found to be involved in high-salt-induced hypertension and dementia

Two key physiological systems found to be involved in high-salt-induced hypertension and dementia

Simple, low-cost clip uses a smartphone's camera and flash to monitor blood pressure

Simple, low-cost clip uses a smartphone's camera and flash to monitor blood pressure

Modest reduction in beta-amyloidogenic processing of APP may be a viable strategy to prevent Alzheimer's disease

Modest reduction in beta-amyloidogenic processing of APP may be a viable strategy to prevent Alzheimer's disease

Tracking changes in blood vessels may hold clues to early detection of neurodegenerative diseases

Tracking changes in blood vessels may hold clues to early detection of neurodegenerative diseases

$4.5 million grant to fund research exploring link between exercise and slowing Alzheimer's progression

$4.5 million grant to fund research exploring link between exercise and slowing Alzheimer's progression

Study shows an association between type 2 diabetes and developing dementia in later life

Study shows an association between type 2 diabetes and developing dementia in later life

Case study: Experimental lecanemab treatment causes adverse outcomes in 65-year-old woman with Alzheimer's disease

Case study: Experimental lecanemab treatment causes adverse outcomes in 65-year-old woman with Alzheimer's disease